This content is machine translated Highlights from the ASCO Congress New treatment options for melanoma At the ASCO Congress, updates on immunotherapy and kinase inhibitors in melanoma were among the topics presented. Current research is yielding some promising insights into new treatment methods, for example…
View Post 3 min This content is machine translated Actinic keratosis Physicians should reconsider their therapy habits At this year’s Melanoma Congress in Hamburg, the question was raised whether the most commonly used treatment options for actinic keratosis (AK) are the most effective and cost-effective. Furthermore, the…
View Post 4 min This content is machine translated New anticoagulants Questions of practical application are to be clarified The new anticoagulants rivaroxaban, apixaban, and dabigatran promise several benefits, but are not suitable for all patient populations. Various questions arise in primary care practice, which were discussed at this…
View Post 4 min This content is machine translated Diabetes mellitus What are the rare forms of diabetes? The classification criteria for the widespread disease diabetes have changed again and again over the years. Since 2000, immune-mediated type 1 forms have been distinguished from type 2 forms, which…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia New therapies urgently needed At the ESMO Congress in Amsterdam, speakers from various countries discussed the latest results and therapy recommendations in the field of chronic lymphocytic leukemia. Overall, chemoimmunotherapy with fludarabine, cyclophosphamide (FC),…
View Post 4 min This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
View Post 6 min This content is machine translated 5th Interdisciplinary Prostate Cancer Symposium Metastatic prostate cancer – New therapeutic options Prostate cancer is the most common male tumor in Western countries and is the second leading cause of cancer-related death in Switzerland. In particular, metastatic castration-resistant prostate cancer (mCRPC) is…
View Post 3 min This content is machine translated Cardiology Update Renal denervation as safe and effective hypertension control The cardiology seminar at Medidays focused on three topics: blood pressure control, myocardial disease, and triple therapy for atrial fibrillation (AF) and stenting. In the treatment of resistant hypertension, renal…
View Post 1 min This content is machine translated Metastatic colorectal carcinoma Determination of mutational RAS status is important in mCRC The results of the FIRE-3 study, presented at this year’s European Cancer Congress in Amsterdam, emphasize the importance and relevance of RAS mutation analysis (KRAS and NRAS) for first-line treatment…
View Post 3 min This content is machine translated Folic acid Better informed about the prevention of spina bifida At the annual meeting of the Folic Acid Offensive Switzerland, various speakers from medicine and science discussed the local supply situation and possible opportunities for improvement. In particular, the lack…
View Post 4 min This content is machine translated ASCO Congress What is the potential of adjuvant therapy and genetic analysis? Current research desiderata on melanoma were presented at this year’s ASCO Congress. Immunotherapy is considered the basis of today’s adjuvant treatment, as radiotherapy is no longer recommended due to too…
